Biotech Stocks in the News; Insmed Inc. (NASDAQ: $INSM), Scythian Biosciences (TSX.V: $SCYB.V), Celgene (NASDAQ: $CELG)

Biotech Stocks in the News; Insmed Inc. (NASDAQ: $INSM), Scythian Biosciences (TSX.V: $SCYB.V), Celgene (NASDAQ: $CELG)

September 7, 2017 – Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks issues a sector snapshot for the biotech sector as Insmed Incorporated (Nasdaq:INSM) sees massive gains this week on news of ‘Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium Avium Complex (MAC)’.

Read this news in full at

http://www.investorideas.com/news/2017/biotech/09071Stocks.asp

Top-Line Efficacy Data

Scythian Biosciences Corp. (TSX.V: SCYB.V) (http://scythianbio.com/), a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination, announced on Tuesday, September 5^th that Maghsoud Dariani had become the Chief Scientific Officer of the Company. Mr. Dariani was previously on the Company's advisory board and has over 35 years of experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani's experience includes, among other things, management positions at Semorex, Focus Pharmaceuticals, Celgene (NASDAQ:CELG), and Chiral Pharmaceuticals.

Scythian Biosciences Corp. (TSX.V: SCYB.V) also announced on August 30^th that it had submitted an initial listing application to list its common shares on the NASDAQ Capital Market

Celgene Corporation (Nasdaq:CELG), a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases, recently announced that it will visit the Nasdaq MarketSite in Times Square. Mark Alles, Chief Executive Officer will ring the Opening Bell on Thursday, September 7^th, 2017 - 9:15 AM to 9:30 AM ET.

For a full list of biotech stocks visit: http://www.investorideas.com/BIS/stock_list.asp

For a full list of marijuana and cannabis stocks visit:

http://www.investorideas.com/Marijuana-Stocks/Stocks_List.asp

About Investorideas.com - News that Inspires Big Ideas

Investorideas.com is a meeting place for global investors, featuring news, stock directories, video, company profiles, interviews and more in leading sectors.  Investorideas.com cannabis/marijuana and hemp content now includeshttp://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com, The 420 Cannabis Investor ideas www.420cannabisinvestorideas.com and the new AI site  Global Cannabis Investing at www.Globalcannabisinvesting.com.

Investorideas.com podcasts are available on iTunes, Tunein, Stitcher. Spreaker.com, iHeart.com and Google Play Music.

Visit the Podcast page at Investorideas.com: http://www.investorideas.com/Audio/

Subscribe to Investorideas.com Podcast RSS:

http://www.investorideas.com/rss/feeds/Podcasts.xml

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details -http://www.investorideas.com/About/News/Clientspecifics.asp

Visit the Scythian Biosciences Corp. (TSX.V: SCYB.V) Profile page:http://www.investorideas.com/CO/SCYB/

Contact Investorideas.com

800-665-0411

Scythian Biosciences Corp. (TSXV: $SCYB.V) Appoints Chief Scientific Officer

Scythian Biosciences Corp. (TSXV: $SCYB.V) Appoints Chief Scientific Officer

TORONTO - September 5, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) is pleased to announce that Maghsoud Dariani has become the Chief Scientific Officer of the Company. Mr. Dariani was previously on the Company's advisory board and has over 35 years of experience in the development and commercialization of products in the pharmaceutical industry. Mr. Dariani's experience includes, among other things, management positions at Semorex, Focus Pharmaceuticals, Celgene and Chiral Pharmaceuticals.

Read this news in full at

http://www.investorideas.com/CO/SCYB/news/2017/09051SCO.asp

About Scythian Biosciences Corp.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian's mission is to be the first accepted drug regimen for concussive treatment. Scythian has recently formed a collaboration with the University of Miami and its world renowned neuroscientific team to conduct pre-clinical and clinical trials of its drug regimen. The University of Miami believes that Scythian's scientific approach shows significant promise and differs from previous approaches to treat this growing problem. The collaboration with the University of Miami allows access to their extensive knowledge base in the fields of traumatic brain injury and concussions and allows for Scythian's clinical studies to be undertaken at their world-class facilities.

Gillian A. Hotz, PhD, is leading Scythian's program at the University of Miami. Dr. Hotz is a nationally recognized behavioral neuroscientist and expert in neurotrauma, concussion management, and neurorehabilitation. She has extensive experience in neurocognitive testing. Dr. Hotz has been the co-director of University of Miami Miller School of Medicine's Concussion Program since 1995.

Scythian is also endorsed by Pro Football Legends and the World Boxing Association on its mission.

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Investor Ideas Adds Biotech Stocks $PZRX, $SRRA, $SBBP, $SYN

Investor Ideas Adds Biotech Stocks $PZRX, $SRRA, $SBBP,  $SYN

 ALSEN.PA, ALVMG.PA, ALPHA.PA; OCC.AX, RHS.AX, VBS.AX; RLM.L, SCLP.L; WNT.ST, XBRANE.ST, OV.ST; 115180.KQ, 019170.KS; SLV.W

Mining, Energy and Tech Stocks also Updated-New Payments & Fintech Section added to Tech Stocks List

Point Roberts, WA, Delta BC – September 1, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its global stock directories in biotech, mining, energy, and tech.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listings for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

Read this news in full at

http://www.investorideas.com/news/2017/main/09011Stocks.asp

Visit http://www.investorideas.com/TSS/stock_list.asp for full Payments & Fintech Stocks list.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.comsite to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:

From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

http://www.investorideas.com/membership/

Services for Publicly traded companies:

http://www.investorideas.com/Investors/Services.asp

Investorideas.com CSE service provider directory listing:

http://thecse.com/en/services/services-for-listed-companies

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411

Scythian Biosciences Corp. (TSXV: $SCYB.V) Applies for Listing of Common Stock on NASDAQ

Scythian Biosciences Corp. (TSXV: $SCYB.V) Applies for Listing of Common Stock on NASDAQ

TORONTO - August 30, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (TSXV: SCYB) (the "Company") is pleased to announce that it has submitted an initial listing application to list its common shares on the NASDAQ Capital Market.

The Company's common shares have traded on the TSX Venture Exchange (the "TSXV") under the symbol "SCYB" since August 8, 2017.

Read this news in full at

http://www.investorideas.com/CO/SCYB/news/2017/08301NASDAQ.asp

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Concussion and TBI Treatment Company Scythian Biosciences (TSX.V: $SCYB.V) Retains The Weinberg Group for FDA IND and IND Consulting Services

Concussion and TBI Treatment Company Scythian Biosciences (TSX.V: $SCYB.V) Retains The Weinberg Group for FDA IND and IND Consulting Services

TORONTO - August 29, 2017 (Investorideas.com Newswire)   FDA news - Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) reports  it has entered into a consulting arrangement with The Weinberg Group and has retained The Weinberg Group's services for assistance with the Company's FDA application process, including pre-IND and IND consulting services.

Read this news in full athttp://www.investorideas.com/CO/SCYB/news/2017/08291WeinbergGroup.asp

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Scythian Biosciences Corp. (TSX.V: $SCYB.V) Retains The Weinberg Group To Provide FDA Consulting Services

Scythian Biosciences Corp. (TSX.V: $SCYB.V) Retains The Weinberg Group To Provide FDA Consulting Services

TORONTO - August 28, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) is pleased to announce that it has entered into a consulting arrangement with The Weinberg Group and has retained The Weinberg Group's services for assistance with the Company's FDA application process, including pre-IND and IND consulting services.

Read this news in full at

http://www.investorideas.com/CO/SCYB/news/2017/08281FDAConsulting.asp

About Scythian Biosciences Corp.

Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian Biosciences Corp. (TSX.V: SCYB)

is a Featured biotech and marijuana company on Investorideas.com

Visit Profile page: http://www.investorideas.com/CO/SCYB/

Get News Alerts on Scythian Biosciences Corp.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.

Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Investor Ideas Adds Biotech Stocks to Directories: $CZO.V; $CFRX, $HTBX, $KMPH; $IPIX, $HGEN

Investor Ideas Adds Biotech Stocks to Directories: $CZO.V; $CFRX, $HTBX, $KMPH; $IPIX, $HGEN

Other Biotech Additions: $NXTMH.OL, $NANO.OL; $CANTA.ST, $IBT-B.ST;  $170900.KS; $FTT.AX, $IMU.AX; $4593.T; $ALHYG.PA; $MXCT.L, $MPH.L

Mining, Energy, Water and Cannabis Stocks also Updated

Point Roberts, WA, Delta BC – August 25, 2017 – Investorideas.com, a global news source and investor resource covering actively traded sectors announces this week’s additions to its global stock directories in biotech, mining, energy, water and cannabis.

Investorideas.com tracks companies in high profile trading sectors and makes ongoing additions to its stock directories for each sector.  Listings for the stock directories include companies on the TSX, OTC, NYSE, NASDAQ and global stock exchanges.

Read this news in full at

http://www.investorideas.com/news/2017/main/08251Stocks.asp

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Ideas

www.Investorideas.com  is a meeting place for global investors, featuring news, stock directories, video, podcasts, company profiles, interviews and more in leading sectors.

Sectors we cover include tech, bitcoin and blockchain, biotech, mining, energy, renewable energy, water stocks, marijuana and hemp stocks, food and beverage (including organic and LOHAS, wine), defense and security (including biometrics), Latin America, sports, entertainment, luxury brands and gaming.

The Investorideas.com content portfolio goes beyond the www.investorideas.comsite to include 12 blogs on Blogger.com, 7 Artificial Intelligence (AI) websites on the Grid and the Waternewswire.com, all featuring Investorideas.com news and content.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Investor Ideas Directories for global investors:

From water stocks to gold and mining stocks, renewable energy, nanotech, defense, technology, biotech and more – use our stock directories and access them online 24/7 with login as a member to find your next big idea!

http://www.investorideas.com/membership/

Services for Publicly traded companies:

http://www.investorideas.com/Investors/Services.asp

Investorideas.com CSE service provider directory listing:

http://thecse.com/en/services/services-for-listed-companies

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:http://www.investorideas.com/About/Disclaimer.asp.

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.  Global investors must adhere to regulations of each country.

Contact Investorideas.com

800-665-0411